A former Jersey City resident admitted in federal court to selling a fentanyl analogue that he was placed in pills and sold as Percocet and Xanax, Acting U.S. Attorney Rachel Honig announced.
Darryl Hinkson, 46, formerly of Jersey City, pleaded guilty by videoconference before U.S. District Judge Claire C. Cecchi to an information charging him with conspiracy to distribute and possess with the intent to distribute 100 grams or more of a fentanyl analogue.
From September 11th, 2018, to October 18th, 2018, Hinkson conspired with others to distribute pills that contained a fentanyl analogue, an illegal controlled substance.
On September 11th, 2018, Hinkson met with a Individual-1 and sold this person approximately 20 pills of purported “Percocet” and 20 pills of purported “Xanax” in exchange for cash.
Then, on September 25th, 2018, Hinkson again met with Individual-1 and sold Individual-1 550 pills of purported “Percocet” and approximately 300 pills of purported “Xanax” in exchange for U.S. currency.
The pills were not, in fact, Percocet or Xanax, but instead contained a fentanyl analogue.
The count of conspiracy to distribute and possess with intent to distribute fentanyl analogue carries a maximum penalty of life in prison and a fine of $10 million. Sentencing is currently scheduled for December 9th, 2021.
Honig credited special agents and task force officers of the Drug Enforcement Administration, under the direction of Special Agent in Charge Susan A. Gibson in Newark, with the investigation leading to today’s guilty plea.
Additionally, the government is represented by Assistant U.S. Attorney Adam Baker of the Opioid Abuse Prevention and Enforcement Unit.